Prohibits the manufacture, distribution, sale and use of nail polish or nail hardener containing certain dibutyl phthalates (DBP), toluene, formaldehyde, formaldehyde resin, camphor, ethyl tosylamide, and xylene; prohibits the use of such nail polish and nail hardener by appearance enhancement businesses.
A01954 would amend New York’s General Business Law to prohibit the manufacture, distribution, and sale of nail polish and nail hardener containing seven specified chemicals: dibutyl phthalates (DBP), toluene, formaldehyde, formaldehyde resin, camphor, ethyl tosylamide, and xylene. It also makes it unlawful for appearance enhancement businesses, such as nail salons and similar personal care establishments, to use nail products containing those substances.
The bill is structured as a consumer and worker-safety measure focused on cosmetic products used in nail services. It would take effect on January 1 following enactment, and would create a new statutory prohibition in the General Business Law governing both product availability in the marketplace and product use in salon settings.
If enacted, the bill would add a new section to the General Business Law and restrict the sale of certain nail products in New York based on their chemical composition. It would affect manufacturers, distributors, retailers, and appearance enhancement businesses by barring products containing the listed ingredients, likely requiring reformulation, inventory changes, and compliance review across the nail care industry.
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate or formal support/opposition in the available record. Based on the bill text alone, the measure appears to be framed as a public-health and consumer-protection proposal aimed at reducing exposure to potentially harmful chemicals in nail products.
The main likely point of contention is the breadth of the chemical ban and its practical impact on the cosmetics and salon industries. Manufacturers and salon operators may be concerned about reformulation costs, product availability, enforcement, and whether the listed substances are already restricted elsewhere, while supporters would likely emphasize health and workplace safety for consumers and nail technicians.